Lessee, Operating Lease, Liability, to be Paid, Year Four of Phathom Pharmaceuticals, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary: Phathom Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four in USD history and change rate from 31 Dec 2019 to 30 Sep 2025.
Phathom Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 30 Sep 2025 was $753,000.
Source SEC data: View on sec.gov

Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)

Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Change (%)

Phathom Pharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$753,000			30 Sep 2025	10-Q	30 Oct 2025	2025	Q3
Q2 2025	$226,000			30 Jun 2025	10-Q	07 Aug 2025	2025	Q2
Q4 2021	$342,000	-$187,000	-35%	31 Dec 2021	10-K	01 Mar 2022	2021	FY
Q4 2020	$529,000	+$348,000	+192%	31 Dec 2020	10-K	30 Mar 2021	2020	FY
Q3 2020	$529,000			30 Sep 2020	10-Q	10 Nov 2020	2020	Q3
Q2 2020	$529,000			30 Jun 2020	10-Q	06 Aug 2020	2020	Q2
Q1 2020	$181,000			31 Mar 2020	10-Q	12 May 2020	2020	Q1
Q4 2019	$181,000			31 Dec 2019	10-K	19 Mar 2020	2019	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.